Author: Eric Hjerpe


Glycolysis and hemolysis: Does it still matter to life insurers?

November 1, 2018 By

Specimen quality is critical for the life insurance underwriting process. With advances in lab testing protocol, do glycolysis and hemolysis still matter?


Three things an insurer should consider when implementing a pilot

October 18, 2018 By

A pilot can be an effective tool for measuring the impact of a new product or workflow. Here are 3 things to consider when implementing a pilot.


Industry survey insights: The impact of tobacco, alcohol, and drug use on anti-selection

November 2, 2017 By